120 related articles for article (PubMed ID: 15099754)
1. Isolation of human antibodies to tumor-associated endothelial cell markers by in vitro human endothelial cell selection with phage display libraries.
Mutuberria R; Satijn S; Huijbers A; Van Der Linden E; Lichtenbeld H; Chames P; Arends JW; Hoogenboom HR
J Immunol Methods; 2004 Apr; 287(1-2):31-47. PubMed ID: 15099754
[TBL] [Abstract][Full Text] [Related]
2. Molecular addresses of tumors: selection by in vivo phage display.
Li XB; Schluesener HJ; Xu SQ
Arch Immunol Ther Exp (Warsz); 2006; 54(3):177-81. PubMed ID: 16736105
[TBL] [Abstract][Full Text] [Related]
3. Cloning, isolation and characterization of human tumor in situ monoclonal antibodies.
Wu H; Pancook JD; Beuerlein G; Chilton T; Pecht G; Huse WD; Watkins JD
Cancer Immunol Immunother; 2002 Apr; 51(2):79-90. PubMed ID: 11904732
[TBL] [Abstract][Full Text] [Related]
4. Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy.
Bagley RG; Rouleau C; Weber W; Mehraein K; Smale R; Curiel M; Callahan M; Roy A; Boutin P; St Martin T; Nacht M; Teicher BA
Microvasc Res; 2011 Nov; 82(3):253-62. PubMed ID: 21958527
[TBL] [Abstract][Full Text] [Related]
5. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78.
Jakobsen CG; Rasmussen N; Laenkholm AV; Ditzel HJ
Cancer Res; 2007 Oct; 67(19):9507-17. PubMed ID: 17909061
[TBL] [Abstract][Full Text] [Related]
6. Isolation of human prostate cancer cell reactive antibodies using phage display technology.
Popkov M; Rader C; Barbas CF
J Immunol Methods; 2004 Aug; 291(1-2):137-51. PubMed ID: 15345312
[TBL] [Abstract][Full Text] [Related]
7. [Expression and identification of phage display library for Fab fragments of colorectal cancer-related antibodies].
Sun X; Wu BP; Xiao B; Zhang ZS; Lai ZS
Di Yi Jun Yi Da Xue Xue Bao; 2002 Aug; 22(8):678-83. PubMed ID: 12376247
[TBL] [Abstract][Full Text] [Related]
8. Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor.
Figini M; Martin F; Ferri R; Luison E; Ripamonti E; Zacchetti A; Mortarino M; Di Cioccio V; Maurizi G; Allegretti M; Canevari S
Cancer Immunol Immunother; 2009 Apr; 58(4):531-46. PubMed ID: 18704410
[TBL] [Abstract][Full Text] [Related]
9. Discovery of human antibodies against the C5aR target using phage display technology.
Huang L; Sato AK; Sachdeva M; Fleming T; Townsend S; Dransfield DT
J Mol Recognit; 2005; 18(4):327-33. PubMed ID: 15706605
[TBL] [Abstract][Full Text] [Related]
10. Generation and selection of immunized Fab phage display library against human B cell lymphoma.
Shen Y; Yang X; Dong N; Xie X; Bai X; Shi Y
Cell Res; 2007 Jul; 17(7):650-60. PubMed ID: 17621306
[TBL] [Abstract][Full Text] [Related]
11. Screening human antibody libraries against carcinoma cells by affinity purification and polymerase chain reaction.
Reiersen H; Berntsen G; Stassar M; Cochlovius B
J Immunol Methods; 2008 Jan; 330(1-2):44-56. PubMed ID: 18082761
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor vasculature with homing peptides from phage display.
Ruoslahti E
Semin Cancer Biol; 2000 Dec; 10(6):435-42. PubMed ID: 11170865
[TBL] [Abstract][Full Text] [Related]
13. Generation and preliminary characterization of an antibody library with preferential reactivity to human colorectal cancer cells as compared to normal human blood cells.
Liebman MA; Williams BR; Daley KM; Sharon J
Immunol Lett; 2004 Feb; 91(2-3):179-88. PubMed ID: 15019288
[TBL] [Abstract][Full Text] [Related]
14. Plexin D1 expression is induced on tumor vasculature and tumor cells: a novel target for diagnosis and therapy?
Roodink I; Raats J; van der Zwaag B; Verrijp K; Kusters B; van Bokhoven H; Linkels M; de Waal RM; Leenders WP
Cancer Res; 2005 Sep; 65(18):8317-23. PubMed ID: 16166308
[TBL] [Abstract][Full Text] [Related]
15. Phage peptide display.
Newton J; Deutscher SL
Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
[TBL] [Abstract][Full Text] [Related]
16. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein.
Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O
BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody to human esophageal cancer endothelium inhibits angiogenesis and tumor growth.
Zhang Y; Ran Y; Yu L; Hu H; Zhou Z; Sun L; Lou J; Yang Z
Anticancer Res; 2006; 26(4B):2963-70. PubMed ID: 16886621
[TBL] [Abstract][Full Text] [Related]
18. Identification of one vasculature specific phage-displayed peptide in human colon cancer.
Zhao X; Hu J; Huang R; Yang L
J Exp Clin Cancer Res; 2007 Dec; 26(4):509-14. PubMed ID: 18365546
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
[TBL] [Abstract][Full Text] [Related]
20. Guided selection of an anti-gamma-seminoprotein human Fab for antibody directed enzyme prodrug therapy of prostate cancer.
Zhang Q; Zhang SH; Su MQ; Bao GQ; Liu JY; Yi J; Shen JJ; Hao XK
Cancer Immunol Immunother; 2007 Apr; 56(4):477-89. PubMed ID: 16868778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
